{
    "clinical_study": {
        "@rank": "38352", 
        "acronym": "RANSuP", 
        "brief_summary": {
            "textblock": "The purpose of this registry is to collect the real life data on Sensor Augmented pump\n      therapy usage in type 1 DM patients treated with Medtronic Insulin pumps and countinuous\n      glucose monitoring systems in Germany."
        }, 
        "brief_title": "RANSuP Registerstudie", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Focus of the Study is to Collect Data and to Get Experience in the Application of Glucose Sensors in the Therapy With Insulin Pumps Under Daily Life Conditions", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with signed informed consent\n\n          -  Type 1 DM and has been on insulin pump therapy for at least 3 months prior to\n             signature of the informed consent\n\n          -  patients use CGM component as part as part of the CSII therapy for a minimum of 1\n             month\n\n        Exclusion Criteria:\n\n          -  participation in any other trial\n\n          -  any disease or drug treatment that can interfere with the outcome of sensor usage\n\n          -  using CGM in CSII < 3 days/week\n\n          -  patients not willing to sign informed consent\n\n          -  abuse of alcohol or drugs (exception of nicotine consumption)\n\n          -  eating disorder, anorexia, bulimia or other mental disorders"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "6 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Type 1 diabetes mellitus"
            }
        }, 
        "enrollment": {
            "#text": "75", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01718522", 
            "org_study_id": "CEN_G_DB_1"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 17, 2014", 
        "number_of_groups": "1", 
        "official_title": "Registerstudie: Anwendung Und Nutzen Der Sensorunterst\u00fctzten Pumpentherapie (SuP) Unter Alltagsbedingungen (RANSuP)", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "primary outcome based on:\nFrequency of hypoglycaemia\u00b4s under SaP (AUC in hypoglycaemic region <70mg/dl and time spent in hypoglycaemic region)\nFrequency of hypoglycaemia\u00b4s (glucose values < 40 mg/dl)", 
            "measure": "to assess the glycemic control in the study population:", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01718522"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "HbA1c, mean glucose concentration, standard deveation of glucose concentration, AUC in hyperglycaemic region (>160mg/dl), glucose excursions after meals (amplitude of excursions), time spent in hyperglycaemic region (>160mg/dl), day time of appearance of dysglycaemic events", 
            "measure": "Parameters of glycaemic control", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Medtronic", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}